Eli Lilly (LLY) Curent Deferred Tax Liability (2011 - 2015)

Eli Lilly (LLY) has reported Curent Deferred Tax Liability for 5 consecutive years, with $943.6 million the latest figure, recorded in Q3 2015.

• Curent Deferred Tax Liability for Q3 2015 came in at $943.6 million, down 30.23% year-over-year; the trailing twelve-month figure through Sep 2015 was $943.6 million (down 30.23% YoY), and the FY2014 annual result was $1.5 billion, up 84.98% from the prior year.
• Curent Deferred Tax Liability was $943.6 million for Q3 2015 at Eli Lilly, up from $912.8 million in the prior quarter.
• Over five years, Curent Deferred Tax Liability peaked at $1.5 billion in Q4 2014 and troughed at $422.3 million in Q4 2011.
• Average Curent Deferred Tax Liability over 5 years is $963.2 million, with a median of $913.6 million recorded in 2013.
• Year-over-year, Curent Deferred Tax Liability jumped 148.16% in 2012 and slumped 30.23% in 2015.
• Over 5 years, Curent Deferred Tax Liability stood at $422.3 million in 2011, then surged by 148.16% to $1.0 billion in 2012, then declined by 24.35% to $792.8 million in 2013, then jumped by 84.98% to $1.5 billion in 2014, then tumbled by 35.66% to $943.6 million in 2015.
• Per Business Quant data, the three most recent Curent Deferred Tax Liability figures were $943.6 million in Q3 2015, $912.8 million in Q2 2015, and $1.3 billion in Q1 2015.